Description
The ARPA‑H SBIR/STTR Broad Agency Announcement (BAA) seeks innovative small‑business proposals across seven high‑impact health‑technology topics, ranging from fertility diagnostics to AI‑assisted neurosurgical robotics. Awards are offered as Phase I (feasibility), Direct‑to‑Phase II, or Fast‑Track (combined Phase I/II) contracts on a firm‑fixed‑price basis. Topics include:
• Development of an affordable annual fertility‑status test for women (Topic 01).
• Next‑generation bioadhesive platforms for tissue sealing in wet, dynamic environments (Topic 02).
• A plug‑and‑play synthetic‑biology platform for toxin removal with cross‑sector applications (Topic 03).
• Curative, non‑surgical therapies for endometriosis (Topic 04).
• Commercialization pathways for technologies originating from prior ARPA‑H funding (Topic 05).
• Rapid, low‑cost diagnostic assay for multi‑system autoimmune disease (Topic 06).
• High‑resolution virtual human brain for AI‑assisted neurosurgical robotics (Topic 07).
Key submission points: Stage 1 solutions due July 17 2026; Stage 2 deadlines vary (Sept 11 2026 or Oct 1 2026). Phase I typically 6‑12 months; Phase II 12‑24 months (some topics up to 36 months). Eligible applicants are U.S. small businesses (≤500 employees) meeting SBA SBIR/STTR criteria.
Attached files
Contact
Business Innovation Division(Business Innovation Division)